The influence of comorbidity on the risk of access-related bacteremia in chronic hemodialysis patients

Access‐related bacteremia is an important cause of morbidity in chronic hemodialysis patients. The incidence of bacteremia is higher in patients dialyzing through a tunneled central venous catheter (TCVC) compared with an arteriovenous fistula (AVF). Our aim was to explore if this is explained by pa...

Full description

Saved in:
Bibliographic Details
Published in:Hemodialysis international 2009-01, Vol.13 (1), p.6-10
Main Authors: MAZONAKIS, Emmanouil, STIRLING, Catherine, BOOTH, Karen L., McCLENAHAN, Jenny, HERON, Neil, GEDDES, Colin C.
Format: Article
Language:English
Subjects:
Adult
Aged
Arteriovenous Shunt, Surgical - adverse effects
bacteremia
Bacteremia - epidemiology
Bacteremia - etiology
Catheter-Related Infections - epidemiology
Catheterization, Central Venous - adverse effects
Cohort Studies
Comorbidity
Female
Hemodialysis
Humans
Incidence
Male
Middle Aged
Renal Dialysis - adverse effects
Renal Dialysis - mortality
vascular access
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Access‐related bacteremia is an important cause of morbidity in chronic hemodialysis patients. The incidence of bacteremia is higher in patients dialyzing through a tunneled central venous catheter (TCVC) compared with an arteriovenous fistula (AVF). Our aim was to explore if this is explained by patient comorbidity. Two groups of chronic hemodialysis outpatients were compared: all patients who dialyzed through a TCVC at any time during 2003 and were fit enough to subsequently have a functioning AVF or renal transplant even if it was after 2003 (Group 1; n=93); and all patients who dialyzed through a TCVC in 2003 and were not fit enough to have a functioning AVF or renal transplant (Group 2; n=119). Episodes of bacteremia (n=71) were identified and those not related to access were excluded. Patients in Group 1 were younger than Group 2 (57.5 years vs. 64.8 years; P=0.001). The incidences of bacteremia in Groups 1 and 2 were, respectively, 0.31 and 0.44 episodes per 1000 patient days while dialyzing through an AVF (P=0.77), and 2.21 and 2.27 per 1000 days while dialyzing through a TCVC (P=0.91). The 3‐year actual survival from January 1, 2003 to January 1, 2006 was significantly higher in Group 1 than in Group 2 (80.6% vs. 26.1%; P
ISSN:1492-7535
1542-4758
DOI:10.1111/j.1542-4758.2009.00327.x